Fri Jan 10 18:40:19 UTC 2025: ## Rise in Human Metapneumovirus (HMPV) Cases Sparks Concerns in India and Globally

**New Delhi, India** – A recent increase in Human Metapneumovirus (HMPV) infections in several Asian countries, including India, has prompted heightened surveillance and public health advisories. While health officials emphasize that HMPV is not a new virus and typically causes mild, cold-like symptoms, the surge in cases, particularly in China, has raised concerns.

At least nine HMPV cases have been confirmed in India since January 7th, with reports emerging from Karnataka, Tamil Nadu, Gujarat, Maharashtra, and Ahmedabad. Although the virus has circulated in India for years, the recent increase has led several state governments to bolster their surveillance efforts. Experts, however, have downplayed the significance of tracking individual HMPV cases, noting the virus’s seasonal nature and similarity to other common respiratory viruses.

The World Health Organization (WHO) has acknowledged the rise in HMPV cases in China and other Northern Hemisphere countries, emphasizing that such increases are typical during winter months due to the seasonal nature of many respiratory pathogens, including influenza and RSV. The WHO stresses that most HMPV infections are mild, similar to the common cold, and that most individuals recover within a few days. However, vulnerable populations, such as young children, the elderly, and those with weakened immune systems, may experience more severe symptoms requiring medical attention.

Indian health officials have issued public advisories recommending standard preventative measures such as frequent handwashing, covering coughs and sneezes, and staying home when sick. While some states have formed technical committees to monitor the situation, ministers have repeatedly reassured the public that there is no cause for widespread panic. The virus, they say, is not as serious as COVID-19, and existing healthcare infrastructure is adequately prepared to handle potential cases.

Although no HMPV vaccine is currently available, research into vaccine development is ongoing. The focus remains on preventative measures and managing symptoms for those infected. The situation is being closely monitored, and health authorities are working to provide regular updates and guidance to the public.

Read More